![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Macedo Ana F. Marques Francisco B. Ribeiro Carlos F.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.29, Iss.8, 2006-01, pp. : 697-702
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Can the Global Fund fulfil its expectations?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 457, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Causality Assessment of Adverse Effects: When Is Re-Challenge Ethically Acceptable?
By Li Wan Po A.
Drug Safety, Vol. 24, Iss. 11, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Could electronic databases replace RCTs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 293, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bivalirudin to replace heparin in coronary interventions?
Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. :